| |
| |
|
| Insider
Information: |
Burgstahler David F |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
127,648 |
|
|
Indirect Shares
|
32,047,702 |
|
|
| Direct
Value |
$3,061,327 |
|
|
|
Indirect Value
|
$25,986,071 |
|
|
| Total
Shares |
32,175,350 |
|
|
| Total
Value |
$29,047,398 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
8.0
|
0.0
|
| Percentage
Gain/Loss : |
 123.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Warner Chilcott Ltd |
WCRX |
Director |
2008-03-07 |
20,000 |
2007-03-12 |
0 |
Premium* |
|
|
Angiodynamics Inc |
ANGO |
Director, 10% Owner |
2017-04-12 |
23,988 |
2017-04-12 |
381,406 |
Premium* |
|
|
Syneos Health Inc |
SYNH |
Director, 10% Owner |
2017-05-23 |
38,758 |
2017-05-23 |
3,648 |
Premium* |
|
|
Lantheus Holdings, Inc. |
LNTH |
Director |
2017-09-07 |
13,248 |
2017-09-07 |
39,831 |
Premium* |
|
|
Wideopenwest, Inc. |
WOW |
Director |
2018-01-10 |
31,654 |
2018-01-10 |
3,733 |
Premium* |
|
|
Organogenesis Holdings Inc |
ORGO |
|
2019-08-19 |
0 |
2021-05-14 |
7,888,220 |
Premium* |
|
|
Osmotica Pharmaceuticals Plc |
OSMT |
Director, 10% Owner |
2020-11-20 |
0 |
2023-01-27 |
23,730,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ORGO |
Organogenesis Holdings In... |
|
• • • |
2019-09-11 |
4 |
B |
$5.75 |
$2,570,429 |
I/I |
447,000 |
18,561,265 |
0.01 |
- |
|
| ORGO |
Organogenesis Holdings In... |
|
• • • |
2019-09-12 |
4 |
B |
$6.25 |
$2,585,344 |
I/I |
413,900 |
18,975,165 |
0.01 |
- |
|
| ORGO |
Organogenesis Holdings In... |
|
• • • |
2019-09-06 |
4 |
B |
$5.18 |
$2,592,300 |
I/I |
500,000 |
18,077,265 |
0.01 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-08-31 |
4 |
S |
$17.36 |
$2,638,737 |
I/I |
(152,001) |
65,263 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • • |
2016-11-18 |
4 |
D |
$15.68 |
$6,408,510 |
I/I |
(408,706) |
765,590 |
0 |
- |
|
| OSMT |
Osmotica Pharmaceuticals ... |
Director |
– • • |
2022-08-08 |
4 |
B |
$1.55 |
$12,400,000 |
I/I |
8,000,000 |
23,730,864 |
2.25 |
% |
|
| ORGO |
Organogenesis Holdings In... |
|
• • • |
2020-11-17 |
4 |
B |
$3.25 |
$14,108,540 |
I/I |
4,322,657 |
29,840,171 |
0.01 |
% |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • • |
2016-11-21 |
4 |
S |
$9.00 |
$22,500,000 |
I/I |
(2,500,000) |
4,282,208 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • • |
2016-11-18 |
4 |
S |
$15.68 |
$32,791,490 |
I/I |
(2,091,294) |
1,014,058 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • • |
2016-08-05 |
4 |
S |
$14.62 |
$32,895,000 |
I/I |
(2,250,000) |
1,555,407 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • • |
2017-03-17 |
4 |
S |
$12.20 |
$36,600,000 |
I/I |
(3,000,000) |
3,442,208 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • • |
2017-04-12 |
4 |
S |
$16.00 |
$37,600,000 |
I/I |
(2,350,000) |
381,406 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • • |
2017-05-09 |
4 |
S |
$13.40 |
$40,200,000 |
I/I |
(3,000,000) |
2,602,208 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • • |
2017-06-20 |
4 |
S |
$14.87 |
$44,610,000 |
I/I |
(3,000,000) |
1,762,208 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-08-14 |
4 |
D |
$17.15 |
$91,985,551 |
I/I |
(5,363,589) |
0 |
0 |
- |
|
65 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
